12 real-world colorectal cancer studies in one resource
Clinical trials tell part of the story. But what happens when therapies move into everyday practice, where patient profiles are more complex and treatment decisions rarely follow a straight line?
Our new curated booklet brings together 12 retrospective studies from U.S. community oncology settings, using EHR and claims data to reveal how care unfolds in the real world. These findings go beyond controlled environments to show what researchers often need most: context.
Inside, you’ll find evidence that can inform your next model or analysis:
- How sequencing regorafenib and trifluridine/tipiracil impacts survival
- Where biomarker testing falls short — and why it matters for outcomes
- Cost trends and social determinants shaping early-onset colorectal cancer
These insights can help you refine assumptions, identify gaps and strengthen evidence strategies for colorectal cancer research.
